Should This Patient Be Tested for Hepatitis?
Yes, this adult male patient presenting with genital or rectal STI symptoms should be offered hepatitis B screening, but hepatitis C screening is not routinely indicated based solely on STI symptoms unless additional risk factors are present.
Hepatitis B Screening
Primary Recommendation
All persons attending STD clinics should be offered hepatitis B vaccine and screening 1. The CDC guidelines explicitly state that sexually active heterosexual men and women in whom another STD was recently diagnosed should receive hepatitis B screening 1.
Screening Approach
For adults attending STD clinics, prevaccination serologic screening may be cost-effective 1. However, the first dose of vaccine should be administered at the time of testing to avoid compliance issues 1. The preferred test is total antibody to hepatitis B core antigen (anti-HBc) because it detects both resolved and chronic infection 1.
Key Considerations
- Among STD clinic patients ≥25 years old, 28% had evidence of past HBV infection versus only 7% in those <25 years 2
- This suggests age-stratified screening may be particularly cost-effective in older patients
- A vaccination history should be obtained, as anti-HBc testing won't identify vaccine-induced immunity 1
Hepatitis C Screening
Risk-Based Approach Required
Hepatitis C screening is not routinely recommended for all STD clinic attendees based solely on genital/rectal symptoms. However, screening should be offered if the patient has:
- Men who have sex with men (MSM) - particularly important given recent evidence 3, 4
- Current or past injection drug use - the strongest predictor of HCV positivity 3
- HIV coinfection 5, 6
- Multiple sex partners or history of other STIs 7
The 2020 USPSTF recommends one-time universal screening for adults aged 18-79 years 6, but this is a general population recommendation, not specific to STI clinic settings.
Testing Method
If indicated, screen with anti-HCV antibody testing followed by confirmatory PCR for positive results 6.
Clinical Algorithm
Step 1: Obtain sexual and drug use history
- Sexual orientation and practices
- Number of partners
- Injection drug use history
- Prior STI diagnoses
Step 2: Hepatitis B management
- Offer anti-HBc screening to all STD clinic patients (especially if ≥25 years old)
- Administer first dose of HBV vaccine simultaneously
- Complete vaccination series based on test results
Step 3: Hepatitis C assessment
- Screen if MSM, injection drug use history, HIV-positive, or multiple high-risk factors
- Otherwise, defer to general population screening recommendations (one-time screening ages 18-79)
Important Caveats
- Hepatitis A should be considered in MSM with rectal symptoms, as sexual transmission occurs in this population 1, 8
- The evidence base for hepatitis screening in STI clinics is primarily from the 1990s guidelines 2, 1, 2, though the principles remain valid and are supported by more recent data 9, 10
- All patients testing positive require linkage to hepatology care, as effective antiviral treatments significantly reduce morbidity and mortality 5, 6
- Periodic rescreening is appropriate for patients with ongoing risk behaviors 5, 6
The distinction is critical: hepatitis B screening is indicated for STI clinic attendees as a routine practice, while hepatitis C screening requires additional risk stratification beyond the STI diagnosis alone.